Patients With Autoimmune Diseases Ask: What is “ASIA”?

The 9th International Congress on Autoimmunity, which included 3,000 doctors and scientists from around the world, commenced in 2014 to discuss one of the most intriguing and important items in the field of autoimmunity: the discovery of a new post-vaccine disorder associated with vaccine aluminum adjuvants called “Autoimmunity/Inflammatory Syndrome Induced by Adjuvants,” also known as ASIA.

Scientists and organizations like the Children’s Medical Safety Research Institute have long explored autoimmunity and the relationship between aluminum adjuvants in vaccines and adverse autoimmune responses. Aluminum is a known neurotoxin to all organisms, and a breadth of scientific research has demonstrated that aluminum plays a significant role in the development of dementia, autism, and Parkinson’s disease. Aluminum exposure has also been linked to cancer and Alzheimer’s disease, among other adverse health conditions.

Defining ASIA

ASIA is therefore only the latest autoimmune syndrome in a long list of disorders associated with aluminum adjuvants.

ASIA was first discovered in 2011 by Yehuda Shoenfeld, who characterizes the disorder as encompassing a wide range of symptoms, including weakness, anxiety, rashes, fatigue, sleep disorders, and arthritis, just to name a few. The disorder also refers to any environmental factor demonstrated to trigger autoimmune conditions. This means that aluminum adjuvants are just one of the many environmental factors that can be associated with ASIA. Squalene, a chemical component of vaccines used on Gulf War military members is also linked to autoimmune disorders that fall under the ASIA criteria. ASIA symptoms can manifest within week or years of an aluminum-adjuvant containing vaccine injection.

At the 9th International Autoimmunity Congress, the ASIA Syndrome was the subject of several presentations, including one by Dr. Carlo Perricone. He was among four presenters voted by his peers to present in a final Plenary Session. Interest in Dr. Perricone’s talk and the ASIA Syndrome highlighted the concern among scientists that autoimmune diseases are rapidly increasing, there are few effective treatments, diagnosis has become more difficult due to diverse symptoms, and there is a great need for more research to understand instigators and treatment options to help a rising tide of sick patients. His talk based on his research, “Autoimmune/inflammatory syndrome induced by adjuvants (ASIA) 2013: Unveiling the pathogenic, clinical and diagnostic aspects, underscored the need to understand how vaccine adjuvants are contributing to such serious adverse events such as narcolepsy that was linked to a new adjuvant in some flu vaccines.

The International ASIA Registry

The 9th International Congress on Autoimmunity announced that an official international ASIA registry would be established, and this registry officially opened in January of 2015. The registry is currently being used as a tool to analyze the nature and prevalence of autoimmune diseases throughout the world; with this data, researchers hope to learn more about the specific causes of autoimmunity. Currently, approximately 70% of registered cases followed administration of the Hepatitis B vaccination.

Animal studies have also demonstrated similar adverse autoimmune conditions upon overexposure to aluminum, such as general weakness and muscular atrophy in sheep. Research conducted by leading adjuvant researcher Christopher Shaw found that mice injected with aluminum at levels corresponding to what’s found in vaccines displayed social interaction deficits and elevated anxiety levels.

Find more information about the ASIA Registry and learn how to submit a case study here.

 

Understanding the Autism Spectrum Disorder

Do you know an individual with Autism Spectrum Disorder? That your answer to this question is “yes” is more probable than it’s ever been before. Today, 1 in every 68 children in the U.S. will be born with ASD, an astonishing ratio considering that less than fifty years ago, just 4 in 10,000 children were born with this disorder. Since the 1980s, ASD has affected an exponentially larger number of children with each passing decade, and though the cause of ASD has yet to be determined, it’s important to continue to raise awareness and enhance our understanding of this disorder, as do organizations like the Children’s Medical Safety Research Institute.

So what should you know about ASD?

ASD is a neurodevelopmental disorder that affects both boys and girls of every ethnicity, though research has shown that boys have a higher likelihood of developing autism than girls. Individuals with this disorder are considered to be on a spectrum, because this disorder’s severity and the way in which it manifests can vary significantly. Unlike other disorders, ASD is not defined by a readily identifiable set of symptoms that are largely uniform across an affected population.

However, there are social, behavioral, and language impairments that are common among individuals on the spectrum. These include, but are not limited to:

  • Difficult making eye contact
  • Difficulty understanding facial cues
  • Delayed language development
  • Difficulty sustaining a conversation
  • Social and emotional distance
  • Repetitive phrases and movements
  • Unique ways of communicating needs

Children with ASD typically begin showing symptoms between 12 and 18 months, which makes identifying ASD in infants challenging. Detecting ASD early is advantageous because research suggests that the sooner children receive intervention, the greater their potential for improved symptoms. There is no cure for ASD, which means that ASD symptoms can remain with a child for the entirety of his or her life. This makes effective intervention even more imperative; though an individual may always have ASD, with intervention, he or she may be able to live life in a more functional, independent capacity.

Naturally, parents are often the first to notice that their young child does not show signs of normal social, linguistic, and behavioral development. However, it’s also important to emphasize that parents are typically the only ones who know their child well enough to make such an early judgment; parents should therefore be diligent in their efforts to monitor development and immediately seek a professional opinion when suspicions arise.

Given that 3.5 million individuals live with ASD in the U.S. today, we have a responsibility to invest our time and effort into learning more about this disorder, including its causes and possible treatments.

 

 

Scientific Organizations Join Together for Autism Research

April is always a month of hope for the autism community, as April is Autism Awareness Month. During this time, the U.S. raises recognition, support, and funding for one of the most prevalent neurodevelopmental disorders affecting young children today. This year, amid the nation’s ongoing fundraisers, events, and social media campaigns, organizations devoted to autism research will come together at the AutismOne Cutting-Edge Autism Conference,® to be held in Chicago. The annual conference, which attracts over one thousand international guests and dozens of leading presenters, will feature the research of scientific organizations like Focus for Health as well as the Children’s Medical Safety Research Institute. The Children’s Medical Safety Research Institute focuses on discovering causal factors underlying a range of chronic illnesses affecting children, including autism.

Specifically, at the AutismOne Cutting-Edge Autism Conference® this year, the Children’s Medical Safety Research Institute will speak on their landmark research involving aluminum and HPV vaccines in a presentation entitled, “Aluminum Toxicity Track and the HPV Vaccine Safety Track.” CMSRI has communicated research findings about aluminum’s toxicity to both children and adults, and has focused much of their research on the adverse effects of exposure via vaccine aluminum adjuvants. CMSRI has most recently raised awareness about new HPV vaccines, which are administered in multiple doses and contain alarmingly twice as much aluminum adjuvants as previous HPV vaccines.  Despite the significant amount of research that has been collected on the dangers of aluminum adjuvants, the FDA has yet to take any steps towards reducing aluminum concentrations in commonly-administered childhood vaccines, and as evident from the latest HPV vaccine, is even willing to let pharmaceutical companies increase aluminum adjuvant concentrations despite there being no evidence of safety.

The adverse effects of aluminum adjuvants first gained widespread attention after Drs. Christopher Shaw and Lucija Tomljenovic published their groundbreaking paper, “Etiology of Autism Spectrum Disorders: Genes, Environment, or Both?” which concluded that while there may be genetic factors at play in the etiology of autism, there is credible evidence to strongly suggest that environmental factors like vaccine aluminum adjuvants are also influencing a child’s risk for developing autism.

The Children’s Medical Safety Research Institute also recently hosted the 3rd International Symposium on Vaccines at the end of March. The symposium featured 15 presentations concerning autoimmune diseases and the role of adjuvants in vaccines; presenters of diverse scientific concentrations, such as neuroscience, genetics, and immunology, were all in attendance to discuss their research

Through conferences, symposiums, and continued research, organizations like the Children’s Medical Safety Research Institute are striving to make meaningful progress towards discovering causes for the autism epidemic. Given that the government has been less than receptive to research on these topics, it seems that only with the persistent voices of these independent research organizations will progress ever be made.

 

Is There a Vaccine Debate Occurring? It Doesn’t Seem Like It.

When analyzing coverage of the recently reignited vaccine debate, it seems as though there’s not much of a debate occurring at all. Rather, media outlets and commentators have quickly dismissed those that maintain doubts about the safety of vaccines as illogical or misinformed, without understanding the reasoning behind their views.  This imbalanced coverage should strike those on both sides of the issue as highly problematic. If scientific understanding is to truly advance, the voices and concerns of minority groups shouldn’t be overtly marginalized or suppressed, especially in light of an abundance of credible supporting evidence.

In the last three decades, extensive research has been conducted by multiple scientists and organizations that demonstrate links between vaccine administration and a risk of chronic illness, disability, and neurodevelopmental disorders. These researchers comprise a group of highly-qualified and experienced scientists from around the world. In 2013, Canadian scientists Dr. Lucija Tomljenovi and Christopher Shaw found that the aluminum adjuvants in childhood vaccines increase a recipient’s risk for developing autism, neurological problems, and autoimmune diseases. In addition to aluminum adjuvants, many vaccines include a number of other toxic elements, including Thimerosal, polysorbate 80 and formaldehyde, to name a few. Dozens of independent research articles have been published on the negative effects of these ingredients, yet the CDC has only relied on a handful of studies, many of which have been identified as maintaining methodological flaws, to support its stance that vaccines pose no threats to recipients.

Immunologists like Dr. J Barthelow Classen have also identified links between vaccines and chronic illnesses like obesity, autism, and diabetes, all of which have increased dramatically among children in recent years. Numerous studies about the adverse health effects of the Gardasil vaccine, flu vaccine, and hepatitis vaccine also provide extensive insight into the potential dangers of vaccination.

There are also a number of prominent health professionals that have made statements in support of the anti-vaccination movement, yet these officials are rarely included in mainstream discussions of vaccination. For example, the former head of the National Institutes of Health, the Red Cross, and the Chair of the White House Cabinet Group on Biotechnology has spoken out against the dismissal of research that suggests a link between vaccines and chronic illness, noting that the research does raise legitimate doubts about vaccine safety.  Even Dr. Diane Harper, a developer of the Gardasil HPV vaccine, has stated she now believes the vaccine has the potential to be harmful to recipients. Prominent researchers and faculty from a number of academic and research institutions like the Children’s Medical Safety Research Institute have made public their concerns about vaccine safety, yet these voices are not the ones the media , nor the government, has acknowledged.

We may also note that pharmaceutical companies and government health organizations have more to gain from asserting that vaccines are safe than those who question vaccine safety do. Widespread vaccination translates into substantial profits for pharmaceutical companies, while those that question the safety of vaccines have nothing to gain, other than safer vaccinations for their children.

Ultimately, a real debate about vaccine safety, one in which evidence from both sides is presented, will pave the way for more productive discussion and a better understanding of the potential risks of vaccination.